Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications

Transplantation. 2003 May 27;75(10):1659-63. doi: 10.1097/01.TP.0000062574.18648.7C.

Abstract

Background: Hepatic allografts from non-heart-beating donors (NHBD) have been cited as a means to expand the supply of donor livers. Concern exists that donor warm ischemic time in addition to subsequent cold ischemia-reperfusion injury may result in damage to sensitive cell populations within the liver. Because the biliary epithelium is sensitive to ischemia-reperfusion injury, the authors surmised that an increased incidence of biliary complications might occur among recipients of an NHBD allograft.

Methods: This study was a retrospective evaluation of NHBD recipients compared to a group of heart-beating donor (HBD) recipients from a single institution.

Results: Fifteen patients received a hepatic allograft from a controlled NHBD donor. NHBD and HBD (n=221) graft survival did not differ at 1 (71.8% vs. 85.4%, P=0.23) or 3 years (71.8% vs. 73.9%, P=0.68). Patient survival at 1 (79% vs. 90.9%, P=0.16) and 3 years (79.0% vs. 77.7%, P=0.8) was also similar. Major biliary complications occurred in five (33.3%) NHBD recipients; 66.6% of the NHBD biliary complications consisted of intrahepatic strictures versus 19.2% among HBD recipients (P<0.01). Major biliary complications in the NHBD recipients resulted in multiple interventional procedures, retransplantation, and death.

Conclusions: Donor warm ischemic time may predispose hepatic allografts to an increased incidence of ischemic type strictures. Although graft and patient survival was similar to a cohort of HBD recipients, caution is urged with the use of these organs.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Bile Ducts, Intrahepatic
  • Biliary Tract Diseases / epidemiology
  • Biliary Tract Diseases / etiology*
  • Biliary Tract Diseases / mortality
  • Biliary Tract Diseases / therapy
  • Constriction, Pathologic
  • Female
  • Graft Survival
  • Heart Arrest*
  • Humans
  • Incidence
  • Liver Transplantation / adverse effects*
  • Male
  • Myocardial Contraction
  • Reoperation
  • Retrospective Studies
  • Tissue Donors*
  • Treatment Outcome